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distinct mouse models of neuropathic pain
Laura Berliocchi1,2*, Maria Maiarù3, Giuseppe Pasquale Varano4, Rossella Russo3, Maria Tiziana Corasaniti1,
Giacinto Bagetta2,3 and Cristina Tassorelli4,5Abstract
Background: Autophagy is a homeostatic degradative process essential for basal turnover of long-lived proteins
and organelles as well as for removal of dysfunctional cellular components. Dysregulation of the autophagic ma-
chinery has been recently associated to several conditions including neurodegenerative diseases and cancer, but
only very few studies have investigated its role in pain processing.
Results: We previously described autophagy impairment at the spinal cord in the experimental model of neuropathic
pain induced by spinal nerve ligation (SNL). In this study, we characterized the main autophagic markers in two other
common experimental models of neuropathic pain, the chronic constriction injury (CCI) and the spared nerve injury
(SNI). The different modulation of LC3-I, Beclin 1 and p62 suggested that autophagy is differentially affected in the
spinal dorsal horn depending on the type of peripheral injury. Confocal analysis of p62 distribution in the spinal dorsal
horn indicated its presence mainly in NeuN-positive cell bodies and occasionally in glial processes, thus suggesting a
predominant expression in the neuronal compartment. Finally, we investigated the consequences of autophagy
impairment on pain behaviour by using the autophagy blocker cloroquine. Intrathecal chloroquine injection in
naïve mice induced spinal accumulation of LC3 and p62 paralleled by significant mechanical hypersensitivity thus
confirming the block in autophagosome clearance and suggesting the participation of the autophagic process in
spinal mechanisms of pain processing. Altogether, our data indicate that spinal autophagy is differentially altered
in different experimental pain models of neuropathic pain and that this process may be relevant for pain control.
Keywords: Spinal nerve ligation, Chronic constriction injury, Spared nerve injury, Neuropathic pain, Autophagy,
LC3, SQSTM1/p62, Beclin 1, ChloroquineBackground
Autophagy is a degradative process by which cells dispose of
cytosolic proteins and organelles [1]. It is an essential physio-
logical mechanism for cellular differentiation, homeostasis
and survival [2,3] but it can also be induced by a series of en-
vironmental and cellular stresses such as nutrients starva-
tion, trophic factors withdrawal and immune stimuli [4].
Autophagy is a multi-step, dynamic process initiated by the
formation of autophagosomes. These are double membrane
vesicles that, after engulfing cytosolic components and fusing
with endosome (amphisomes step), will fuse with lysosomes* Correspondence: berliocchi@unicz.it
1Department of Health Sciences, University “Magna Græcia” of Catanzaro,
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unless otherwise stated.and form autolysosomes for cargoes degradation [5].
Autophagy is also a highly regulated process and one of
its key regulators is the kinase mammalian target of
rapamycin mTOR, which in the presence of growth fac-
tors and abundant nutrients keeps autophagy down [6].
One of the key steps in autophagy regulation is the phos-
phatidylethanolamine conjugation to the microtubule-
associated protein 1 light chain 3 (LC3-I) to form lipidated
LC3-II, which binds to the expanding phagophore and re-
mains associated with autophagosomes even after fusion
with lysosomes [7].
Under normal conditions and particularly in neurons,
autophagy remains at a low basal level and is essential for
the maintenance of cellular homeostasis via the turnover
of energy and cellular building material [8,9]. However, in
recent years, autophagy dysregulation has been implicated
in an increasing number of pathological conditions suchral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Mechanical allodynia in different models of neuropathic
pain. A severe and persistent hypersensitivity developed following
SNL, SNI and CCI surgery. Calibrated von Frey filaments were used to
determine the withdrawal threshold for punctate mechanical
stimulation. Data were expressed as means of ± SEM of threshold of
mechanical sensitivity. ***P < 0.001 for all three models in comparison
to the sham group. SNL n = 6, SNI n = 8, CCI n = 5.
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http://www.molecularpain.com/content/11/1/3as metabolic diseases [10], neurodegenerative [11,12] and
inflammatory diseases [13], cancer [14] and glaucoma [15].
The mechanisms of autophagy dysfunction in these different
pathological conditions are not clearly elucidated yet. For in-
stance, although the importance of neuronal autophagy and
its dysregulation in neurodegenerative disorders is undeni-
able, the exact events leading to autophagy malfunction, the
key steps affected in each specific disease and their cause-
effect relation remain unclear. Autophagosome accumula-
tion has been observed in experimental models and patients
in cases of neurodegenerative disorders associated with the
misfolding and aggregation of specific mutated proteins
such as Alzheimer’s, Parkinson’s and Huntington’s diseases
[16-19]. Although it is still debated whether this would rep-
resent a protective or detrimental mechanism and a cause
or a consequence of the disease, many studies indicate that
autophagy operates as an efficient mechanism for the deg-
radation of aggregation-prone proteins and pharmacological
activation of autophagy has been suggested as a promising
therapeutic strategy in many of these conditions [20].
In contrast to the great effort put into characterising the
molecular mechanisms and the role of autophagy in chronic
neurodegenerative disorders, so far only a few studies have
investigated the role of autophagy in pain processing and
whether dysregulation of this basic homeostatic process
might be relevant also for pain conditions. Impairment of au-
tophagy in the spinal cord after peripheral nerve injury was
first described by our group following spinal nerve ligation
(SNL) [21], and further confirmed by others in this same ex-
perimental model [22,23]. More recently, a role for autophagy
in Schwann cells during axonal peripheral nerve degener-
ation and pain “chronification”was also reported [24].
Here, we extended our initial study and investigated
whether spinal modulation of the main autophagic markers
LC3, Beclin 1 and p62 was common also to other widely
used models of peripheral nerve injury such as the chronic
constriction injury (CCI) of the sciatic nerve [25] and the
spared nerve injury (SNI) model [26].
The different modulation of LC3, Beclin 1 and p62 suggests
that autophagy is differentially affected in the spinal dorsal
horn depending on the type of peripheral injury. To investi-
gate autophagosomes distribution and cellular localization,
p62 expression was investigated in the spinal dorsal horn and
appeared strongly present in neurons. Finally, spinal block of
autophagy with the autophagic flux inhibitor chloroquine in-
duced increased mechanical sensitivity, thus suggesting that
dysfunctional spinal autophagy may be relevant for altered
nociceptive processing.
Results
Spinal nerve injuries induced a severe mechanical
allodynia
In this study, three different models of neuropathic pain
induced by peripheral nerve injury were used: the spinalnerve ligation (SNL) [27], the spared nerve injury (SNI)
[26] and the chronic constriction injury (CCI) [25]. All
these models induced a rapid reduction in threshold of
mechanical sensitivity on the injured side compared to
the sham group (Figure 1), but not on the contralateral
side, as previously described [25-27]. In the SNL model,
the threshold of mechanical sensitivity dramatically de-
creased 1 day after surgery (Figure 1) and remained con-
stant for at least 28 days, as previously described [21]. In
the SNI model, a reduction in threshold was observed
starting 1 day after surgery; maximal mechanical sensi-
tivity was reached at 7 days (Figure 1) and kept constant
for at least 14 days (data not shown) [26]. After CCI of
the sciatic nerve, a robust mechanical allodynia devel-
oped starting from 1 day after surgery (Figure 1) and
lasting for at least 28 days as previously described [28].
In all three models, the difference in mechanical sensi-
tivity between the injured group and the respective sham
group was statistically significant (p < 0.001, determined
by two-way ANOVA).
Autophagy modulation following spinal nerve injury
Microtubule-associated protein 1 light chain 3 (LC3) was
the first mammalian protein discovered to be specifically
associated with autophagosomal membranes [7]. It exists
in a non-lipidated and a lipidated form, usually referred to
as LC3-I and LC3-II, respectively. Because of its essential
role in the expansion step of autophagosome formation,
LC3-II is regarded as the most reliable marker protein for
macroautophagy [29].
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Figure 2 Expression of autophagic markers in the spinal dorsal
horn in three different models of peripheral nerve injury (SNL, SNI
and CCI). The representative Western blots show levels of the
autophagic markers LC3-I, LC3-II, Beclin 1 and p62 and voltage-gated
calcium channel subunit α2δ-1 in the spinal dorsal horn ipsilateral (I) and
contralateral (C) to the side of injury.
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analysis in the spinal dorsal horn 7 days after SNL and
CCI, and 14 days following SNI (Figure 2). Increased levels
of LC3-II in the ipsilateral (I) versus the contralateral (C)
dorsal horn were observed in the SNL model as shown by
Western blot (Figure 2) and by densitometric and statis-
tical analysis (p < 0.05; Figure 3). Similarly, a statistically
significant increase in LC3-II levels was observed in the
ipsilateral dorsal horn after SNI but not after CCI
(Figures 2 and 3B and C). No statistically significant
variation in LC3-I expression was detected in any of
the three models (Figures 2 and 3).
Autophagic activity does not only rely on increased syn-
thesis or lipidation of LC3, but on a series of regulatory
proteins orchestrating different autophagic steps from for-
mation of autophagosomes to fusion with the lysosomes
and subsequent release of breakdown products. Here, we
first analysed the expression of Beclin 1, a key protein in
the induction of autophagy essential for autophagosomes
formation [30]. To understand whether LC3-II formation
observed in the SNL and SNI models was due to an up-
stream induction of autophagy, the expression of Beclin 1was analysed. A statistically significant increase of Beclin 1
was observed on the injured side of the spinal dorsal cord
in the CCI model (p < 0.05; Figures 2 and 3C). On the
contrary, no significant difference in Beclin 1 expression
was observed after SNI (Figures 2 and 3B), as well as SNL
(Figures 2 and 3A), thus suggesting a different upstream
modulation of autophagy in the three models.
Besides LC3, levels of autophagy substrates can be used
to monitor autophagic flux. Among these, p62/SQSTM1
is one of the best-known and more widely used [1]. p62 is
selectively incorporated into autophagosomes through dir-
ect binding to LC3 and efficiently degraded in functional
autolysosomes [31,32], thus serving as a readout of autoph-
agic degradation. Therefore, p62 analysis may provide use-
ful information on the final degradative steps of autophagy.
We have previously shown that in the SNL model, LC3-II
formation is accompanied by p62 accumulation suggesting
that increased LC3-II levels might be a consequence of de-
fective autophagosome clearance rather than autophagy in-
duction [21]. To verify this hypothesis also in the case of
injury induced by SNI or CCI, p62 levels were evaluated by
Western blot in the spinal dorsal horn of mice that under-
went the three different types of surgery.
While SNL induced a statistically significant accumu-
lation of p62 on the side ipsilateral to injury (Figures 2
and 3A), no differences in p62 levels were observed be-
tween the contra- and ipsi-lateral side following SNI or
CCI of the sciatic nerve (Figures 2 and 3B and C).
As in our previous work [21], we used the calcium chan-
nel subunit α2δ-1 as biochemical marker of a neuropathic
pain state because of its known upregulation ipsilaterally to
the injury and its confined expression to the correspondent
lumbar portion of spinal cord following SNL [33]. A statis-
tically significant upregulation of the α2δ-1 subunit was de-
tected in the dorsal spinal cord of the injured side in SNL
and SNI groups, although not after CCI (Figures 2 and 3)
and was used in all experiments as internal control for cor-
rect cord sampling. The lack of a significant upregulation in
the CCI model is in line with the previous observation that
the upregulation of this subunit is correlated to the severity
of the injury [34]. The densitometric analysis of the calcium
subunit and the different autophagic markers is plotted in
Figure 3 according to the model.
p62 is mainly expressed in neurons in the spinal dorsal
horn following spinal nerve ligation
Currently available antibodies are not able to distinguish
between cytosolic LC3-I and autophagosome-bound LC3-
II. We selected the autophagic substrate p62 to investigate
autophagosomes localization and distribution in spinal
dorsal horn following peripheral nerve injury induced by
SNL. Immunohistochemistry showed that p62 was ubiqui-
tously expressed in the spinal cord, with high levels of ex-
pression in the superficial layers of the ipsilateral (I) dorsal
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Figure 3 Densitometric analysis of autophagic markers changes
detected by Western blot in the spinal dorsal horn following
three different models of peripheral nerve injury (SNL, SNI and
CCI). The SNL model (A) was characterised by increased LC3-II and
p62, whereas in the SNI (B) and CCI (C) only LC3-II and Beclin 1
increase were detected, respectively. A statistically significant
upregulation of the voltage-gated calcium channel subunit α2δ-1
was observed in the injured side of the SNL and the SNI model.
Signals from each band were normalised towards the corresponding
GAPDH signal. Values were expressed as mean ± SEM. *P < 0.05, SNL
n = 8, SNI n = 5, CCI n = 5.
Berliocchi et al. Molecular Pain 2015, 11:3 Page 4 of 11
http://www.molecularpain.com/content/11/1/3horn following SNL (Figure 4). To further characterize the
cellular localization of p62, double immunofluorescent la-
bellings were performed using antibodies against p62
combined with the neuronal marker NeuN, the astro-
cytic marker GFAP or the microglial marker Iba-1 (not
shown). Imunolabelling showed a main presence of p62
in NeuN-positive cell bodies (Figure 4) but spots of p62
immunoreactivity could also be detected within glial
processes, as shown by the presence in GFAP-positive
structures (Figure 4). A certain degree of p62 immuno-
reactivity was present in the neuropile suggesting that
p62 might be expressed also in neuronal processes.Spinal block of autophagy results in pain behaviour
In order to verify the relevance of a downstream impair-
ment of autophagy at spinal cord level and its consequences
for pain processing, the anti-malaria drug chloroquine was
used as a pharmacological tool to block autophagy. To-
gether with bafilomycin A1 and NH4Cl, chloroquine is one
of the main chemicals used to inhibit autophagy [29]. Like
NH4Cl, chloroquine neutralises the lysosomal pH and by
inhibiting endogenous protein degradation causes the accu-
mulation of sequestrated material in either autophago-
somes or autolysosomes. Moreover, chloroquine has been
suggested to block autophagosomes fusion with lysosomes
[29]. Chloroquine was administered to naïve mice by a daily
intrathecal injection at the dose of 300pmoles/3 μl for 3
consecutive days. The behavioural test was conducted daily
2 h after injection for 3 days. On the third day, mice were
sacrificed after the test and the spinal dorsal horn dissected
for Western blot analysis (Figure 5). Chloroquine treatment
induced LC3-II formation and p62 accumulation in treated
mice, when compared to vehicle-injected mice, but did not
affect Beclin 1 levels (Figure 5) thus confirming the drug
action on a downstream step of the autophagic process.
Moreover, the behavioural test (von Frey’s) carried parallel
to the treatment (Figure 6A) showed a significant reduction
in threshold of mechanical sensitivity starting from day 2
in chloroquine-injected mice in comparison to vehicle-
injected mice (p < 0.01 determined by two-way ANOVA;
Figure 6B) thus suggesting that impaired spinal autophagy
can result in altered mechanical sensitivity.Discussion
Pain is a common feature of many neurodegenerative
diseases [35-37], in which autophagy is being extensively
studied as an important player in the progression of the
pathology [17], and indicated as a new promising thera-
peutic target [37]. Understanding the role of autophagy
in the mechanisms of pain processing may represent a
valuable tool in pain management also in these specific
patients populations.
So far only a few studies have investigated the role of au-
tophagy in pain processing. Impairment of autophagy in
the spinal cord following peripheral nerve injury was first
described in the spinal nerve ligation (SNL) model by our
group [21] and further confirmed in this same experimen-
tal model by others [22,23]. Here, we investigated whether
spinal modulation of some of the main autophagic
markers (i.e. LC3, Beclin 1 and p62) observed following
SNL was common also to other widely used models of
peripheral nerve injury such as the chronic constriction
injury (CCI) of the sciatic nerve [25] and the spared nerve
injury (SNI) model [26]. In the SNL, increased LC3-II
levels were paralleled by strong p62 accumulation but no
significant LC3-I and Beclin 1 increase, suggesting the
Figure 4 Distribution and cellular localisation of p62 immunoreactivity in the spinal dorsal horn following SNL. (A) Although
ubiquitously expressed (see positive cell bodies in the ventral spinal cord), high levels of p62 were present in the superficial layers of the dorsal
horn, particularly on the side ipsilateral to injury (A, insert). Spots of p62 immunoreactivity were detected within glial processes as shown by
some p62 immunolabelling within GFAP-positive structures (B and C arrowheads). However, high p62 levels were particularly evident in some
neuronal cell, as shown by the strong signal within NeuN-positive cell bodies (D and E arrows). Each image is a single focal plane from spinal cord
sections of mice undergone SNL; B, C, D, E show ipsilateral side. Scale bars: A 250 μm; B, D 100 μm; C 20 μm; E, 50 μm.
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flux [21] rather than an induction of the process.
Indeed, LC3-II upregulation may be indicative of in-
creased autopagic flux but also of defective autophagosome
clearance. In this last case, LC3-II upregulation will be asso-
ciated to p62 accumulation, as this autophagy substrate will
not be efficiently degraded by the autophagosomes [29,38].
The SNI and the CCI models showed completely differ-
ent patterns, with no significant change in LC3-I expressionin any of the two models (Figures 2 and 3) and LC3-II, the
lipidated LC3 form known to be associated with autopha-
gosomes [7], being significantly increased in the dorsal
spinal cord ipsilateral to injury following SNI but not CCI
(Figures 2 and 3). Monitoring LC3-II conversion is consid-
ered one of the most reliable methods for monitoring au-
tophagy. However, a concomitant increase in both the rate
of autophagosome formation and LC-3 downstream deg-
radation can show normal steady-state levels in LC3-II,
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Figure 5 Effect of chloroquine intratechal injection on Beclin 1,
LC3 and p62 in the spinal dorsal horn. (A) Representative
Western blots of Beclin 1, LC3 and p62 protein levels after
chloroquine (300pmoles/3 μl, i.t.) according to the treatment
protocol in Figure 6A. (B) Densitometric analysis of Beclin 1, LC3-II
and p62 expression. While Beclin 1 expression was not affected, LC3-
I, LC3-II and p62 levels were significantly increased in the chloroquine
group compared to the vehicle-injected group. The appearance of a
second band has been previously suggested as a p62 splicing variant
or a partially cleaved product [42]. Signals of each band were normalised
to the respective GAPDH. Data were expressed as mean ± SEM.
*P < 0.05. Vehicle n = 3, choloroquine (CQ) n = 6 (n = 5 for Beclin 1).
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accumulation can result from autophagy induction, but also
from its impairment at one of the last steps such as fusion
with the lysosomes or cargo degradation [38]. Therefore, it
is preferable to integrate LC3 studies with the analysis of
other components of the autophagic machinery such as
members of the initiation complex (i.e. Beclin 1) or autoly-
sosomes substrates (i.e. SQSTM1/p62) [29]. Studies on the
regulatory role of Beclin 1 on autophagy suggested that
Beclin 1 complex is involved in autophagosome formation
at an early stage [30] and this complex is essential for the
recruitment of other Autophagy-related (Atg) proteins to
the pre-autophagosomal structure [40]. In the SNL model,
LC3-II was not associated to any significant ipsilateral in-
crease of LC3-I and Beclin 1 [21] and, similarly, no differ-
ences in LC3 and Beclin 1 were detected between the ipsi-
and contralateral side of dorsal spinal cord following SNI
(Figures 2 and 3). On the contrary, Beclin 1 was clearly
upregulated in the ipsilateral side compared to the contra-
lateral following CCI, suggesting a possible induction of
autophagy in this model.
One of the best-known autophagic substrates is p62/
SQSTM1, a key LC-3-binding protein, which serves as a
link between LC-3 and ubiquitinated proteins [32]. p62 and
p62-bound polyubiquitinated proteins become incorpo-
rated into the completed autophagosome and are degraded
in autolysosomes. Because of the correlation between au-
tophagy modulation and p62 levels [32,41,42], this substrate
is considered a useful readout of autophagic degradation
[29,43]. Indeed, p62 levels increase when autophagy is im-
paired [42]. In the SNL model, ipsilateral p62 accumulation
was observed in the presence of high LC3-II levels without
changes in LC3-I and Beclin 1 expression, thus pointing to-
wards a block in the final degradative steps of autophagy
[21]. On the contrary, no differences in p62 levels were ob-
served between the ipsi- and contra-lateral side following
CCI and SNI (Figures 2 and 3). Because of the spinal accu-
mulation detected following SNL by Western blot analysis,
the distribution and cellular localisation of p62 in the spinal
dorsal horn was also investigated by confocal microscopy in
this model. The protein appeared ubiquitously expressed in
the spinal cord, with high levels of expression also in cell
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Figure 6 Effect of chloroquine intratechal injection on mechanical
sensitivity. (A) Baseline mechanical thresholds were assessed in naïve
mice for 2 consecutive days before the first injection. Chloroquine
(300pmoles/3 μl) or vehicle were then injected intrathecally once daily.
Two hours after treatment, mechanical sensitivity was measured by Von
Frey’s test. The protocol was repeated for three consecutive days.
(B) Localised spinal block of autophagy significantly reduced the
threshold of mechanical sensitivity, in comparison to vehicle-treated mice.
Data were expressed as mean± SEM of the threshold of mechanical
sensitivity. **P < 0.01. Vehicle n = 3, chloroquine (CQ) n = 6.
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ons. In the superficial layers of the dorsal horn, p62 immu-
nolabeling appeared increased in the side ipsilateral to
injury. It was mainly expressed in NeuN-positive cell
bodies, but spots of p62 immunoreactivity could be
detected in glial processes as shown by p62 imunolabelling
within GFAP-positive structures. Immunoreactivity was
also observed in the neuropile suggesting that p62 might be
expressed also in neurites. Further morphological and
functional studies will be needed to verify the presence and
the role of the autophagic machinery in this specific cellular
compartment that could be a relevant component in pain
signalling. Indeed, accumulating evidence has revealed that,
not only is autophagy uniquely regulated in neurons, but it
may also have a distinct function and regulation within the
axonal compartment, the dendrites and the soma [44,45].
Autophagy participation in axon homeostasis has been
recently suggested by degeneration of axon terminals
induced in non-damaged neurons by autophagy suppres-
sion [46]. Also, a close relationship between the autophagic
process and neuritic alterations has been suggested in several
in vitro and in vivo models of neurites dystrophies [47].
Local autophagy can sequester presynaptic components andtherefore modulate presynaptic function [48] as well as se-
lectively degrade postsynaptic receptors [49,50]. In addition
to the well-established role in cellular homeostasis and stress
response, the emerging role of autophagy in neurotrans-
mitter release modulation and synaptic as well dendritic
remodelling may reveal important also in the context of
the structural and functional changes occurring at spinal
dorsal horn during chronic pain states [51,52]. Although
LC-3 and Beclin 1 co-localisation with calretinin-positive
neurons in the spinal cord has been recently reported
[22], further functional studies are mandatory to verify
whether autophagy dysregulation may play a role in the
loss of GABA inhibitory tone [53,54] or in the glutamate
excitatory unbalance [55] observed in the spinal cord fol-
lowing peripheral nerve injury. Also, the observation that
morphine can induce Beclin 1 and Atg5-dependent au-
tophagy in human neuroblastoma SH-SY5Y cells and in
the rat hippocampus [56] together with the recent report
that autophagy in the spinal dorsal horn might play a role
in morphine tolerance [57] seem to support an involvement
of this process in the mechanisms of central sensitization
occurring at the spinal cord. Altogether, the analysis of
LC3, Beclin 1 and p62 indicated the occurrence of dis-
tinct patterns of autophagy modulation in the three
models studied. While a block in completion of basal au-
tophagy seemed to be associated with SNL injury, spinal
autophagy appeared increased and functional following
CCI of the sciatic nerve. The trend of spinal autophagy
modulation after SNI appeared comparable to what ob-
served following SNL, though not all changes were statisti-
cally significant. Although all three models of peripheral
nerve injury produce signs of both ongoing and evoked
pain and similar behavioural phenotypes, differences in the
nature of injury, in the extent of neuronal damage and le-
sion site [58] may be responsible for the different molecular
alterations observed in respect to autophagy modulation in
the spinal dorsal horn. Because of p62 accumulation ob-
served following SNL, we hypothesised that in this model a
block may have occurred at the final steps of autophagy
degradation. A transitory beneficial effect of autophagy in-
hibition on pain behaviour has been recently shown in the
SNL model [22]. However, autophagy was inhibited with 3-
methyladenine (3-MA), a phosphatidylinositol 3-kinase
(PtdIns3K) inhibitor that effectively blocks an early stage of
autophagy by inhibiting the class III PtdIns3K but that can
also promote autophagy by inhibition of the class I enzyme
[29,59]. Here, we verified the relevance of spinal autophagy
for pain processing by blocking the autophagic flux locally
at the lumbar spinal cord by intrathecal injection of the au-
tophagy blocker chloroquine. Chloroquine is a lysosomo-
tropic agent that elevates the lysosomal pH inactivating
lysosomial enzymes but also the fusion step between autop-
hagosomes and lysosomes. By doing so, it induces a block
of autophagic flux and inhibits the degradation of the
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agy [29]. When injected intrathecally in naïve mice, chloro-
quine was able to modulate the spinal autophagic
machinery as shown by the increase in LC3-II and p62, in-
dicative of autophagosomes accumulation (Figure 5). More-
over, in these same animals, chloroquine induced a
significant reduction in threshold of mechanical sensitivity
(Figure 6) supporting the concept that impaired autoph-
agy may contribute to pain.
The exact mechanisms through which autophagy may
be linked to mechanisms of abnormal spinal plasticity in
pain signaling need to be further elucidated. However, sev-
eral drugs are able to modulate autophagy at different
steps either as inhibitors or activators [60] and a number
of clinical trials [61,62] are currently evaluating their use
in human conditions, such as neurodegenerative diseases
and cancer, often associated with pain syndromes. There-
fore, a better understanding of the role of this physio-
logical process also in the context of pain appears to be
relevant for a better management of chronic conditions
and as a potential novel tool for pain control.
Material and methods
Animals
Male C57Bl/6 mice (20-22 g) (Charles River, Italy) were used
for all experiments. Animals were kept in their home cages
at 21°C and 55% relative humidity with a light–dark cycle of
12 am (lights on at 08:00 am); food and water were provided
ad libitum. Experimental protocols were in accordance to
the guidelines of the Italian Ministry of Health for animal
care (D.L. 116/1992). All efforts were made to minimise ani-
mal suffering and to reduce the number of animal used.
Surgery
Spinal Nerve Ligation
The spinal nerve ligation (SNL) was performed according
to the Kim & Chung model [27]. Under 2% isoflurane
anaesthesia, a middle incision was made in the skin of the
back at the L2-S2 levels and the left paraspinal muscles
separated from the spinal process at the L4-S1 levels. The
left lumbar L6 transverse process was carefully removed to
identify theL4andL5 spinal nerves.The left L5 spinal nerve
was isolated and tightly ligated with a 6–0 silk thread.
Complete hemostasis was confirmed and the wound was
sutured. The surgical procedure for the sham group was
identical to the SNL group, except that the spinal nervewas
not ligated.
Spared Nerve Injury
The spared nerve injury (SNI) was performed as described
by Decosterd and Woolf [26]. Under 2% isoflurane
anaesthesia the skin on the lateral surface of the thigh was
incised and a section made directly though the biceps
femoris muscle exposing the sciatic nerve and its threeterminal branches: the sural, common peroneal and tibial
nerves. The common peroneal and the tibial nerves were
tight-ligated with 5–0 silk and sectioned distal to the
ligation. Great care was taken to avoid any contact with or
stretching of the spared sural nerve. Complete hemostasis
was confirmed and the wound was sutured. For sham
control, the procedure involved exposure of the sciatic
nerve and its branches without any lesion.
Chronic Constriction Injury
Chronic constriction injury (CCI) of the sciatic nerve
was performed according to the model described by
Bennet & Xie [25]. Under 2% isoflurane anaesthesia,
the common sciatic nerve was exposed and dissected
from the surrounding connective tissue. Three loosely
constrictive ligatures (5–0 silk) were tied around the
nerve with a 1–1.5 mm distance between ligatures.
The muscle and skin were sutured after complete
hemostasis was confirmed. For sham surgery, the
sciatic nerve was exposed as described above but no
contact was made with the nerve.
For all the models, after surgery foot posture and general
mice behaviour were monitored throughout the postopera-
tive period.Drug treatment
Chloroquine (Sigma, c6628) was dissolved in saline to
have a final 100 μM solution. Mice were divided into
two groups, one treated with chloroquine and the
other one treated with vehicle (saline). Intrathecal injec-
tion (i.t.) was performed as previously described [63,64].
Briefly, the i.t. injections were given by percutaneous
lumbar puncture through an intervertebral space at the
level of the 5th or 6th vertebrae. The drugs were admin-
istered i.t. in a volume of 3 μl using a 10 μl Hamilton
microsyringe. A flick of the tail was used as an indica-
tion that the needle had penetrated the dura mater.
After injection the syringe was rotated and removed and
posture and locomotion were checked. A 3 μl i.t. injec-
tion was performed once a day for three days. After in-
jection animals were kept under observation and after
2 h the behavioural test was performed.Behavioural test
Animals were placed in Plexiglas chambers, located on
an elevated wire grid and allowed to habituate for at
least 1 hour. After this time, the plantar surface of the
paw was stimulated with a series of von Frey monofila-
ments of ascending forces [27,65,66]. The threshold was
determined by using the up-down method as described
by Chaplan and colleagues [67] and the data were
expressed as log of mean of the pain threshold ± SEM.
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Animals were deeply anaesthetized with pentobarbital and
perfused transcardially with saline containing heparin
followed by 4% paraformaldehyde (PFA) in 0,1 M phosphate
buffer (PB). The lumbar spinal cord was dissected out, post-
fixed in 4% PFA for 2 h and then transferred into a 30% su-
crose solution in PB containing 0,01% azide at 4°C, for at
least 24 h. The spinal cord was sectioned on cryostat set at
20 μm thickness. Sections were incubated with a primary
antibody against p62 (anti-p62/SQSTM1, PM045, MBL),
followed by incubation with the appropriate Alexa
Fluor 488-conjugated secondary antibody. For double
immunostainings, sections were sequentially incubated also
with anti-GFAP (astrocyte marker; MAB360, Millipore) or
anti-NeuN (neuronal marker; MAB377, Millipore) or
anti-Iba1 (microglial marker; 019–19741, Wako) anti-
body followed by incubation with the appropriate Alexa
Fluor 594-conjugated secondary antibody. Nuclei were
counterstained with H-33342 (Life Technologies) and all
sections cover slipped with Fluoromount Aqueous Mount-
ing Medium (Sigma). Controls were included omitting the
first or second primary antibodies. Images were acquired by
laser scanning microscopy (Leica TC-SP2 Confocal System;
Leica Microsystems, Milan, Italy) using sequential scanning
and 10X (HC PL Fluotar10X/0.30), 40X (HCX PL APO
40X/1.25) or 63X (HCX PL APO63x/1.4) objectives (Leica
Microsystems, Milan, Italy).
Western blot analysis
ForWestern blot analysis, animals were terminally anaesthe-
tized with CO2 and the spinal cord segment corresponding
to the lumbar area was rapidly removed. The ipsi- and con-
tra-lateral dorsal horn quadrants L4-L5 were quickly dis-
sected out and frozen in liquid nitrogen, then stored at −80°
C until further processing. Each sample was homogenised in
ice-cold lysis buffer (50 mMTris–HCl, pH 8, 150mMNaCl,
1 mM EDTA, 0,1% SDS, 1% IGEPAL, 0,5% Na-deoxyxolate)
in the presence of protease inhibitors (Sigma, P8349) and in-
cubated on ice for 40 min. Samples were then centrifuged at
14,000 x g for 15 min at 4°C. Total protein content was deter-
mined in the supernatants by the Bio-Rad DC Protein Assay
Kit (Bio-Rad Laboratories, Milan, Italy). Equal amounts of total
proteins were separated by sodium dodecyl-sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE, 15%) and transferred
onto PVDF membranes (Immobilon-P, Sigma). After blocking
for 1 hour at room temperature in Tris-buffer saline containing
0,05% Tween 20 (TBST) and 5% non-fat milk, the mem-
branes were incubate with primary antibody: anti-LC3
(1:2000, MBL); anti-Beclin (1:4000, MBL); anti-p62-
SQSTM1 (1:1000, MBL); anti-α2δ-1 (1:1000, Sigma-
Aldrich); anti-GAPDH (1:40000, Ambion). After several
washes, an appropriate HRP-conjugated secondary anti-
body (goat IgG; Pierce Bio-tecnology, USA) was applied
for 1 hour at room temperature. Peroxidase activity wasvisualized using the ECL Western Blotting Detection kit
(ECL, Amersham Biosciences, Italy) and X-ray films
(Hyperfilm ECL, Amersham Bioscence). Signal intensity
was measured using Fiji software (NIH, USA). For quanti-
tative analysis, the Beclin 1, LC3-I, LC3-II, p62 and α2δ-1
signals of each sample were normalized towards the corre-
sponding GAPDH signal.
Statistic
Data were expressed as mean ± SEM and statistically
assessed for differences either by two-way ANOVA (behav-
ioural tests) or by Student’s t-test. Calculations were done
using GraphPad Prism (GraphPad Software Inc or SPSS
software, Chicago, IL).
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